ABSTRACT
Introduction
Langerhans cell histiocytosis (LCH) is caused by an uncontrolled pathogenic clonal proliferation of dendritic cells with Langerhans cell characteristics. [1] No definite etiology has been identified for this disease and it can be triggered by environmental agents and viruses, in particular Epstein-Barr virus. [2] Three clinical subtypes of LCH are recognized.
The unifocal subtype (single system, single site), previously referred to as eosinophilic granuloma, usually affects the bones, lymph nodes, or lungs as the primary sites. [3] The multifocal subtype (single system, multi-ple sites) affects several sites in any particular organ system. Formerly this subtype was recognized as Hand-Schuller-Christian disease with bone lesions, diabetes insipidus, and exophthalmos. [4] The multiple-organ-system subtype, previously referred to as disseminated histiocytosis or Letterer-Siwe disease, affects multiple sites in different organ systems and is seen in the first year of life and has the worst prognosis. [4] The jaws are affected in 10% to 20% of all cases. The most common oral presenting symptom was tooth mobility (50%), followed by pain (35%) and swelling (35%) ( Table 2 ). Fifteen patients (75%) had lesions limited to the oral cavity and were diagnosed as eosinophilic granuloma. The remaining 5 patients (25%) had the disseminated form of disease (Table 3) . 
Discussion
Epidemiologic studies provide important details on the disease occurrence and its microscopic features in various countries. [7] [8] These data will improve detection of high risk populations and help determine various responsible factors. The records available at oral and maxillofacial pathology centers are major information sources for epidemiologic studies of oral lesions. [9] Although there is no previous research about oral LCH in Iranian population, our findings indicated that LCH prevalence in Iran was similar to other countries.
In this research, oral LCH accounted for 0.34% of all oral pathology cases, which was similar to other investigations. [10] [11] [12] Previous epidemiologic studies have reported 17 cases of oral LCH during a period of 40 years, 4 cases in a period of 16 years and 3 cases in a 30-year period, [10] [11] [12] indicating the low prevalence of the disease.
LCH can affect any age group; however, it is more frequent in children. [10] Nevertheless, the mean age of patients in our research was 27 years. In fact, bony lesions of LCH usually occur in patients above 20. Therefore, the mean age of patients with jaw involvement is higher than other groups.
In this study, oral LCH was more frequent in males, generally affecting the posterior region of mandible. This was in agreement with other investigations. [4, 13] The presenting signs and symptoms of oral LCH may be pain, swelling, oral mucosal ulceration, periodontal problems, non-healing extraction sites and granulomatous or hyperkeratotic lesions. [10, [14] [15] These various presentations of oral LCH is due to the fact that either jaws or oral mucosa are involved. Oral LCH in this case series most frequently presented with tooth mobility, pain, and swelling.
Oral LCH lesions are localized or the earliest sign of a disseminated disease [3] . Various frequencies of disseminated form (10-66%) have been reported in the articles. [15] [16] Most patients in our research (75%) had localized lesions and the remaining minority (25%) had systemic involvement. Since oral lesions may be the initial manifestations of a systemic involvement, dental professionals have an important role in early detection of the disease. [17] Once the diagnosis of LCH is established, the patient should be referred by the dentist to an internist for a thorough physical examination, particularly in lymph nodes and abdominal organs to rule out a more disseminated disease. It must be noted that any delay in diagnosis of LCH may lead to a poor response to the treatment.
Conclusion
Like many other countries, the relative frequency of oral Langerhans cell histiocytosis is low in Iranian population and the great majority of cases occur in males. In addition, tooth mobility and periodontal lesions are frequently the early signs of disease. Therefore, in patients with periodontal problems, good oral health, and no response to the treatment, LCH must be considered. Although most cases of oral LCH are localized, a thorough examination should be performed to rule out any systemic involvement.
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